Managing Technology Transfers in Dutch Pharmaceutical Manufacturing Facilities
Technology Transfer Looks Straightforward on Paper. Reality Is Different.
If you read most regulatory guidance, technology transfer in pharmaceutical manufacturing sounds fairly simple.
A process is developed.
The documentation is prepared.
Another site reproduces the process.
Done.
At least, that’s how it often appears in theory.
In practice, it rarely unfolds that neatly.
At SIRE Life Sciences, we spend a lot of time speaking with manufacturing leaders, quality managers and project teams across the Netherlands. And when the topic of technology transfer comes up, the conversation tends to follow a familiar pattern.
Science itself usually isn’t the hardest part.
Alignment is.
Development teams know the process in great detail. Manufacturing teams need that knowledge translated into procedures that actually work on the production floor. Validation teams need to prove the process performs consistently. Quality teams need to review every step.
And everyone is working under regulatory scrutiny.
Sometimes across multiple facilities.
Sometimes against tight timelines.
That combination is what makes technology transfer such an interesting challenge. It’s not just a technical exercise. It’s coordination across science, operations, and compliance.
Across the Dutch life sciences ecosystem particularly around hubs like:
- Leiden Bio Science Park
- Utrecht Science Park
- Pivot Park
technology transfer projects are becoming increasingly common.
New therapies move from development into commercial manufacturing. Companies expand production networks. Facilities take on new products.
All of this requires one thing.
Processes must be transferred reliably from one environment to another.
And that’s where things often become more complicated than expected.
What “Technology Transfer” Actually Means in Pharma
When people talk about technology transfer, they’re usually referring to something quite practical.
A manufacturing process that works in one place needs to work somewhere else.
That might involve:
- moving a product from development into commercial production
- transferring manufacturing between internal sites
- scaling production with a contract manufacturer
- expanding supply across a global manufacturing network
The key objective is consistency.
The receiving facility must be able to manufacture the product with the same quality and reliability as the original site.
Regulators such as the
European Medicines Agency and the
U.S. Food and Drug Administration
expect companies to demonstrate that they fully understand their processes when these transfers occur.
That means documentation.
Validation.
Clear scientific rationale behind every step.
But documentation alone doesn’t guarantee a smooth transfer.
In fact, one manufacturing leader we spoke with recently summed it up quite well:
The process itself wasn’t the difficult part. Aligning all the teams around it was.
That observation comes up more often than people expect.
Why Technology Transfers Become Complex
Most transfer projects start with a clear plan.
Yet once the work begins, several challenges tend to appear.
Interestingly, they’re rarely purely scientific.
Knowledge gaps between development and manufacturing
Development teams often understand a process extremely well.
But translating that knowledge into GMP-ready procedures can take time.
Manufacturing teams need practical guidance. Not just theory.
Equipment differences between sites
Even facilities producing the same product rarely have identical equipment.
Mixers behave differently.
Filtration systems vary.
Environmental conditions change.
Small differences like these can affect how a process performs at scale.
Cross-functional coordination
Technology transfer touches almost every part of a pharmaceutical organization.
Typical teams involved include:
- Process Development
- Manufacturing Science & Technology (MSAT)
- Validation Engineering
- Quality Assurance
- Regulatory Affairs
- Supply Chain
When those teams collaborate closely, transfers move smoothly.
When alignment breaks down, delays often follow.
FAQ’s
1. What is technology transfer in pharma?
Technology transfer is the process of moving manufacturing knowledge from one facility to another.
2. Why is technology transfer important?
It ensures consistent product quality when production moves between sites.
3. What causes technology transfer delays?
Delays usually come from documentation gaps, equipment differences, or team misalignment.
4. How can companies improve technology transfer success?
By using structured planning, clear documentation, and strong cross-team coordination.
5. Why use consultants during technology transfer?
Consultants provide specialized expertise in validation, compliance and project delivery.
One Thing We Often Tell Clients
Technology transfer is sometimes described as a handover.
In reality, it behaves much more like a project.
At SIRE Life Sciences, we often see that the most successful technology transfers are the ones treated as structured project delivery programs rather than simple documentation exchanges.
Successful transfers almost always include:
- clear project ownership
- cross-functional coordination
- defined milestones
- structured risk management
When organizations approach transfers this way, potential issues tend to surface earlier, making them easier to resolve before they impact validation timelines or manufacturing readiness.